Get started
Work

P864: Employees’ views and healthcare utilization following employer-sponsored pharmacogenomic testing at a large US healthcare system

Year: 2024
Type: article
Study design: Observational Study
Abstract: While preemptive pharmacogenomic testing (PGx) has typically been constrained to specialized healthcare programs and consumer testing, voluntary workplace wellness programs that offer genetic testing (wGT) are expanding these opportunities. However, it is unknown whether and how employees respond to results from PGx testing in this setting. This study evaluated self-reported PGx testing outcomes, including healthcare utilization, among employees receiving PGx test results through their employer’s wGT program.
DOI: 10.1016/j.gimo.2024.101778
Authors: Elizabeth Charnysh, Subhamoy Pal, Jonathan Reader, Sarah McCain, Katherine Hendy, Kunal Sanghavi, Wendy Uhlmann, William Feero, Anya Prince, Rachael Brandt, Rebecca Ferber, Veda Giri, Charles Lee, J. Scott Roberts
Institutions: The Jackson Laboratory for Genomic Medicine, University of Michigan, Michigan Medicine, Maine-Dartmouth Family Medicine Residency, University of Iowa, Thomas Jefferson University, Yale Cancer Center
Language: English
Subfield: Pharmacology
Open Access status: gold
Estimated APC paid: $3,200
OpenAlex ID: W4392606923
FWCI:
Cites:
Cited by:
Related to: 10